Evidence map›Paper›PMID 24165979›Full record

ReviewImmunology and cell biology2014

The adaptor protein Crk in immune response.

Dongfang Liu

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunology and cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Immune-Enhancing Effects ofCurrent issues in molecular biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. bioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. T cell receptor (TCR) signaling in health and disease.Signal transduction and targeted therapy · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. POU2F1 induces the immune escape in lung cancer by up-regulating PD-L1.American journal of translational research · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Dongfang Liu1] Center for Human Immunobiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA [2] Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Texas Children's Hospital · US

Funding

Tissue ResourceP50CA126752 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Leonid S Metelitsa · 2007 to 2026
$51.4M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
The adaptor protein Crk in immune responsesR01AI130197 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Dongfang Liu · 2018 to 2026
$4.2M
The adaptor protein Crk in immune responsesR56AI130197 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI LIU, DONGFANG · 2017 to 2023
$874k
Bispecific cytotoxic lymphocytes in HIV-related lymphomaR21HL125018 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2015 to 2016
$449k
HIV-1-Specific CTL Exhaustion at Immune SynapseR21AI124769 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2016 to 2017
$446k
Targeting of Master Signaling Molecule to Restore Functions of Exhausted HIV-specific CTLsR21AI129594 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LIU, DONGFANG · 2017 to 2018
$438k
NCI NIH HHS P50 CA126752NIAID NIH HHS AI36211NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI130197NIAID NIH HHS R21 AI124769NIAID NIH HHS R21 AI129594
6 · The paper itself

Abstract

The adaptor proteins Crk (CT10 (chicken tumor virus number 10) regulator of kinase), including CrkI, CrkII and Crk-like, are important signal molecules that regulate a variety of cellular processes. Considerable progress has been made in understanding the roles of the Crk family proteins in signal transduction, with a focus on cellular transformation and differentiation. However, since Crk was identified in 1988, very few studies have addressed how Crk regulates the immune response. Recent work demonstrates that Crk proteins function as critical signal molecules in regulating immune cell functions. Emerging data on the roles of Crk in activation and inhibitory immunoreceptor signaling suggest that Crk proteins are potential immunotherapeutic targets in cancer and infectious diseases. The aim of this review is to summarize recent key findings regarding the role of Crk in immune responses mediated by T, B and natural killer (NK) cells. In particular, the roles of Crk in NK cell functions are discussed.

Indexed as

AnimalsHumansImmunity, CellularKiller Cells, NaturalProto-Oncogene Proteins c-crkProto-Oncogene Proteins c-crk

Identifiers

PMID24165979
PMCPMC4065865
OpenAlexW2029657525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.